UNSPSC 51183501: Benfosformin

This classification denotes an anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 49030P3C8S. European Medicines Agency schedules Benfosformin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05715MIG. Benfosformin generally arises in the molecular formula C9H12N5O3P.2NA.H2O.

UNSPSC 51183501 Benfosformin is a Commodity code representing a specific pharmaceutical active ingredient procured by state and local health agencies, primarily through state pharmacy benefit managers, Medicaid programs, and public health departments. The code covers benfosformin—a biguanide antidiabetic agent—as a finished pharmaceutical product or bulk active pharmaceutical ingredient for compounding and dispensing through state-administered healthcare programs. State and local procurement under this code involves formulary management, preferred-drug listings, and volume purchasing agreements that typically require competitive bidding or cooperative purchasing through established state pharmaceutical contracts and group purchasing organizations.

The source provided contains no recent state or local contract opportunities posted under UNSPSC 51183501. Without posted RFP, RFQ, IFB, or ITB records, geographic concentration, repeat issuing bodies, and representative solicitation examples cannot be characterized from current market activity. Firms pursuing pharmaceutical-ingredient contracts should monitor state Medicaid agency procurement portals, state health department RFPs for drug formularies and purchasing agreements, and cooperative purchasing vehicle platforms (such as NASPO ValuePoint or state-specific GPOs) for opportunities in this category, as solicitations may be distributed across multiple state health authorities rather than centralized in a single procurement office.